EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 148 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.35 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,252,000 | +59.5% | 73,205 | +77.7% | 0.79% | +92.0% |
| Q1 2022 | $2,039,000 | -51.4% | 41,205 | -50.0% | 0.41% | -4.0% |
| Q4 2021 | $4,196,000 | +82.6% | 82,410 | +100.0% | 0.43% | -14.3% |
| Q3 2021 | $2,298,000 | +26.8% | 41,205 | -2.7% | 0.50% | +54.0% |
| Q2 2021 | $1,813,000 | +26.8% | 42,357 | +23.6% | 0.33% | +24.9% |
| Q1 2021 | $1,430,000 | -10.4% | 34,263 | 0.0% | 0.26% | -23.2% |
| Q4 2020 | $1,596,000 | +12.0% | 34,263 | +2.1% | 0.34% | -9.8% |
| Q3 2020 | $1,425,000 | -6.3% | 33,550 | +5.8% | 0.38% | -2.3% |
| Q2 2020 | $1,521,000 | +76.2% | 31,702 | +69.1% | 0.39% | +45.7% |
| Q1 2020 | $863,000 | -23.4% | 18,751 | 0.0% | 0.26% | +25.6% |
| Q4 2019 | $1,127,000 | +124.5% | 18,751 | +111.2% | 0.21% | +91.8% |
| Q3 2019 | $502,000 | +1.6% | 8,878 | 0.0% | 0.11% | +6.8% |
| Q2 2019 | $494,000 | +10.3% | 8,878 | 0.0% | 0.10% | +8.4% |
| Q1 2019 | $448,000 | +48.3% | 8,878 | +18.4% | 0.10% | +31.9% |
| Q4 2018 | $302,000 | -41.9% | 7,500 | 0.0% | 0.07% | -29.4% |
| Q3 2018 | $520,000 | -38.6% | 7,500 | -33.0% | 0.10% | -41.0% |
| Q2 2018 | $847,000 | -48.0% | 11,200 | -63.8% | 0.17% | -49.7% |
| Q1 2018 | $1,628,000 | +16.2% | 30,900 | +17.9% | 0.34% | -11.8% |
| Q4 2017 | $1,401,000 | +39.0% | 26,218 | +106.4% | 0.39% | +55.4% |
| Q4 2016 | $1,008,000 | – | 12,700 | +158650.0% | 0.25% | – |
| Q2 2016 | $0 | – | 8 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 8 | -99.8% | 0.00% | -100.0% |
| Q4 2015 | $436,000 | +20.1% | 4,913 | +0.2% | 0.12% | +48.7% |
| Q3 2015 | $363,000 | – | 4,904 | +122500.0% | 0.08% | – |
| Q2 2015 | $0 | – | 4 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 3,652,284 | $302,920,000 | 91.10% |
| Hudson Executive Capital LP | 1,901,200 | $157,686,000 | 21.62% |
| JW Asset Management, LLC | 525,755 | $43,606,000 | 9.08% |
| Cormorant Asset Management, LP | 200,000 | $16,588,000 | 2.41% |
| Park West Asset Management LLC | 488,128 | $40,485,000 | 2.36% |
| Opaleye Management Inc. | 50,000 | $4,147,000 | 2.06% |
| Ranger Investment Management | 283,954 | $23,551,000 | 1.71% |
| Pier Capital, LLC | 74,732 | $6,198,000 | 1.06% |
| Bellevue Group AG | 67,700 | $5,615,000 | 0.75% |
| Orbimed Advisors | 671,000 | $55,653,000 | 0.63% |